PAH rs121908253: Understanding the p.Arg408Trp Variant
The rs121908253 variant, also known as p.Arg408Trp, is a specific change in the PAH gene. It is widely recognized in scientific literature as a pathogenic variant associated with phenylketonuria (PKU), an inherited metabolic disorder.
What each genotype means
Typical enzyme activity
You carry two non-variant copies at this position in the PAH gene. This indicates you do not carry the severe p.Arg408Trp (R408W) pathogenic alteration associated with classical phenylketonuria. You have typical phenylalanine hydroxylase enzyme function from this specific locus.
Carried by over 99% of people globally, though slightly less common in parts of Eastern and Central Europe where the T allele is prevalent.
Phenylketonuria carrier
You carry one copy of the c.1222C>T (p.Arg408Trp) variant, making you an asymptomatic carrier for phenylketonuria (PKU). PKU is an autosomal recessive disorder, meaning carriers typically have normal phenylalanine metabolism and show no disease symptoms. Carrier status is primarily relevant for family planning, as having children with another carrier increases the risk of passing on the condition.
Carried by approximately 1 in 100 individuals of general European ancestry, but reaches frequencies around 1 in 20 to 1 in 30 in certain Eastern and Central European populations.
Classic phenylketonuria risk
You have two copies of the severe p.Arg408Trp missense variant in the PAH gene. In clinical genetics, this genotype is classified as pathogenic and is strongly associated with classical phenylketonuria due to a profound loss of phenylalanine hydroxylase activity. Without dietary intervention and medical monitoring, individuals with this genotype develop high blood phenylalanine levels.
Extremely rare in the general worldwide population (roughly 1 in 40,000 to 1 in 100,000 births), though it accounts for up to 10-15% of all diagnosed PKU cases in parts of Eastern and Central Europe.
What is the rs121908253 Variant?
The variant rs121908253, commonly referred to as p.Arg408Trp, is a single nucleotide variant located on chromosome 12 at position 12q23.2. In this specific genetic change, the amino acid arginine is replaced by tryptophan at position 408 of the protein sequence. This variant is classified as a missense mutation, meaning the change in the DNA code results in the production of a protein with a different amino acid than the original. Because the PAH gene is critical for normal metabolic function, changes like this can significantly alter the structure and stability of the resulting enzyme. Researchers track this variant closely because it is one of the most frequently identified genetic changes in individuals diagnosed with phenylketonuria, particularly among populations with European ancestry.
The Role of the PAH Gene
The PAH gene provides instructions for making an enzyme called phenylalanine hydroxylase. This enzyme is primarily active in the liver and is responsible for converting the amino acid phenylalanine, which is obtained through the diet, into another amino acid called tyrosine. When the PAH enzyme is functioning correctly, it keeps phenylalanine levels in the blood within a safe, normal range. However, when the PAH gene contains pathogenic variants, the enzyme may be missing, reduced in quantity, or unable to function properly. This leads to an accumulation of phenylalanine in the body, which can reach levels that are toxic to the brain and nervous system. Understanding the specific impact of variants like rs121908253 helps clinicians and researchers predict how the enzyme's activity might be affected in different individuals.
Research and Clinical Associations
Scientific research has strongly associated the p.Arg408Trp variant with classic phenylketonuria, a severe form of the condition characterized by very low or absent enzyme activity. Studies have shown that individuals who inherit two copies of this variant, or one copy of this variant combined with another pathogenic PAH variant, often experience significant elevations in blood phenylalanine levels. Because this variant is so well-documented, it is frequently included in diagnostic panels for PKU. While the evidence for its pathogenicity is robust, the clinical expression of PKU can vary based on the specific combination of variants an individual carries. It is important to note that genetic testing for this variant is used to understand the underlying cause of metabolic symptoms and should always be interpreted by a qualified medical professional or genetic counselor.
Population Frequency
The p.Arg408Trp variant is not distributed evenly across the globe. It is most commonly observed in populations of European descent, particularly those with Slavic roots, and its frequency follows a geographic gradient across Europe. While it is a major cause of PKU in these regions, it is much less common in other parts of the world, such as East Asia. In some European populations, it is considered the most prevalent PKU-causing allele. Because it is a rare condition overall, the presence of this variant in the general population is low, but it remains a significant focus of study for researchers investigating the epidemiology of inherited metabolic disorders.
What This Information Means for You
If you or a family member have been identified as a carrier of the rs121908253 variant, it is important to understand that this is a recessive trait. Being a carrier typically means having one copy of the variant, which usually does not cause symptoms of PKU. However, if two carriers have a child, there is a chance that the child could inherit two copies of the variant, which may lead to PKU. This information is primarily used for family planning and diagnostic purposes. If you have concerns about your genetic status or family history, you should consult with a medical geneticist or a genetic counselor. They can provide personalized guidance, explain the implications of your specific results, and discuss appropriate testing or monitoring options for your family.
How common is this variant?
The rs121908253 variant is most common in Northern and Eastern European populations, where it is a leading cause of phenylketonuria. Its frequency is significantly lower in other global populations.
Frequently asked questions
Is rs121908253 the same as p.Arg408Trp?
Yes, rs121908253 is the unique identifier (rsID) used in genetic databases to track this specific variant, while p.Arg408Trp describes the actual change in the protein structure.
Does having this variant mean I have PKU?
Not necessarily. PKU is an autosomal recessive condition, meaning it usually requires two copies of a pathogenic variant to manifest. A single copy typically makes you a carrier without symptoms.
Can I change my genotype for this variant?
No, your genetic sequence is inherited from your parents and remains constant throughout your life. You cannot change your genotype through diet or lifestyle.
Should I get tested for this variant?
Genetic testing is usually recommended if there is a family history of PKU or if a newborn screening test indicates high phenylalanine levels. Discuss the necessity of testing with your healthcare provider.
Sources & further reading
Educational information only, last refreshed 10/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908253?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PAH
Pathogenic phenylalanine hydroxylase variant conferring risk of phenylketonuria.
A severe pathogenic missense variant (p.Arg408Trp) in the PAH gene associated with phenylketonuria.
Missense variant (c.1222C>T, p.Arg408Trp) that disrupts phenylalanine hydroxylase activity, associated with phenylketonuria.
Splice-site variant (c.1066-11G>A) causing phenylalanine hydroxylase deficiency.
Splice donor variant (c.1066-11G>A) associated with severe phenylalanine hydroxylase deficiency and phenylketonuria.
Missense variant (p.Arg408Trp) causing severe classic phenylketonuria (PKU) when inherited bi-allelically due to profound loss of phenylalanine hydroxylase activity.